SUBSCRIBE
SUBSCRIBE

Missouri

Signage outside Express Scripts' headquarters in Missouri
Pharmacy benefit managers
Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster
Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.
August 27, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
CENTENE CORPORATION ANNOUNCES 2025 GUIDANCE
December 13, 2024
 · 
12 min read
Press Releases
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
December 10, 2024
 · 
4 min read
Press Releases
CENTENE CORPORATION TO HOST VIRTUAL INVESTOR DAY ON DECEMBER 12, 2024
December 6, 2024
 · 
2 min read
Press Releases
Wugen to Present Clinical Data at the 2024 ASH Annual Meeting Ahead of Pivotal Trial Launch of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
December 5, 2024
 · 
5 min read
Press Releases
CENTENE CORPORATION TO HOST INVESTOR DAY ON DECEMBER 12, 2024
December 3, 2024
 · 
1 min read
Press Releases
Bayer Announces ‘Project Enhanced S3’ to Enable Companies to Realize Additional Sustainability Value from Carbon Removal Projects
November 21, 2024
 · 
4 min read
Press Releases
Pivot Bio Names Jason Hoag Head of North American Commercial Distribution
November 20, 2024
 · 
2 min read
Press Releases
Curium Completes Enrollment Early of Phase 3 SOLAR-RECUR Prostate Cancer Trial
November 19, 2024
 · 
2 min read
Press Releases
Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer Patients
November 15, 2024
 · 
2 min read
Press Releases
Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer
November 14, 2024
 · 
2 min read
Press Releases
Stereotaxis Reports 2024 Third Quarter Financial Results
November 12, 2024
 · 
9 min read
Press Releases
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy
November 7, 2024
 · 
2 min read
Press Releases
Geneoscopy’s Dr. Erica Barnell to Present at Women @ Work Summit and American Gastroenterological Association Workshop
November 7, 2024
 · 
3 min read
Press Releases
MilliporeSigma Invests $76 Million to Expand ADC Manufacturing for Novel Cancer Therapies
October 30, 2024
 · 
7 min read
Press Releases
Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics’ Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals
October 29, 2024
 · 
2 min read
Press Releases
Immunophotonics to Present at the 2024 ThinkEquity Conference
October 29, 2024
 · 
1 min read
Business
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
October 23, 2024
 · 
1 min read
Press Releases
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
October 22, 2024
 · 
3 min read
Press Releases
Cofactor Genomics receives Medicare coverage for OncoPrism®, a machine learning-based RNA oncology test predicting immunotherapy response
October 21, 2024
 · 
1 min read
Press Releases
Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®
October 17, 2024
 · 
6 min read
Load More